In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus

  • Wang, Qian M.D.
  • Xiao, Ze Xiu M.D.
  • Zheng, Xu M.D.
  • Wang, Guihong M.D.
  • Yang, Linlin M.S.
  • Shi, Lina Ph.D.
  • Xiang, Nan M.D.
  • Wang, Xingbing M.D.
  • Zha, Gao-Feng Ph.D.
  • Schett, Georg M.D.
  • Chen, Zhu M.D.

  • First Affiliated Hospital of University of Science and Technology of China, Hefei

    Shenzhen MagicRNA Biotechnology, Shenzhen, China

    First Affiliated Hospital of University of Science and Technology of China, Hefei

    Anqing Municipal Hospital, Anqing, China

    Anhui University of Science and Technology, Huainan, China

    Shenzhen MagicRNA Biotechnology, Shenzhen, China

    First Affiliated Hospital of University of Science and Technology of China, Hefei

    Shenzhen MagicRNA Biotechnology, Shenzhen, China

    Friedrich-Alexander-University Erlangen–Nuremberg, Erlangen, Germany

    First Affiliated Hospital of University of Science and Technology of China, Hefei

New England Journal of Medicine Publish Ahead of Print, September 17, 2025. | DOI: 10.1056/NEJMc2509522
Copyright © 2025 Massachusetts Medical Society. All rights reserved.